Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution
Abstract Psychotropic drugs can induce strong metabolic adverse effects, potentially increasing morbidity and/or mortality of patients. Metabolomic profiling, by studying the levels of numerous metabolic intermediates and products in the blood, allows a more detailed examination of metabolism dysfun...
Guardado en:
Autores principales: | Marie Lenski, Jonathan Sidibé, Mehdi Gholam, Benjamin Hennart, Céline Dubath, Marc Augsburger, Armin vonGunten, Philippe Conus, Delphine Allorge, Aurelien Thomas, Chin B. Eap |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b3236d03c894d60ac978e3c805fe31b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DBnorm as an R package for the comparison and selection of appropriate statistical methods for batch effect correction in metabolomic studies
por: Nasim Bararpour, et al.
Publicado: (2021) -
Improving Access & Use of Psychotropic Medicines
por: World Health Organization -
PSYCHOTROPIC PROPERTIES OF REMEDY “ADAPTOPHYT-15”
por: M. V. Baldandorzhiyeva, et al.
Publicado: (2012) -
Insights gained into respiratory infection pathogenesis using lung tissue metabolomics.
por: Jean A Bernatchez, et al.
Publicado: (2020) -
The use of psychotropic medication during pregnancy: how about the newborn?
por: Kieviet N, et al.
Publicado: (2013)